Adiponectin deficiency increases leukocyte-endothelium interactions via upregulation of endothelial cell adhesion molecules in vivo

Journal of Clinical Investigation

Volumn 117, Issue 6, 2007, Pages 1718-1726

  Ouedraogo, Raogo ^a   Gong, Yulan ^a   Berzins, Brett ^a   Wu, Xiandong ^a   Mahadev, Kalyankar ^a   Hough, Kelly ^a   Chan, Lawrence ^b   Goldstein, Barry J ^a   Scalia, Rosario ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; ANTIINFLAMMATORY AGENT; CELL ADHESION MOLECULE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLOBULAR ADIPONECTIN DOMAIN; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

ADIPONECTIN DEFICIENCY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INTERACTION; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; KNOCKOUT MOUSE; LEUKOCYTE; LEUKOCYTE ADHERENCE; LEUKOCYTE ROLLING; MALE; MICROCIRCULATION; MICROSCOPY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN DEPLETION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UPREGULATION;

ADIPONECTIN; ANIMALS; CELL ADHESION; E-SELECTIN; ENDOTHELIAL CELLS; LEUKOCYTE ROLLING; LEUKOCYTES; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NITRIC OXIDE; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT PROTEINS; UP-REGULATION; VASCULAR CELL ADHESION MOLECULE-1;

EID: 34249900491     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI29623     Document Type: Article

References (67)

1. Goldstein, B.J., and Scalia, R. 2004. Adiponectin: a novel adipokine linking adipocytes and vascular function. J. Clin. Endocrinol. Metab. 89:2563-2568.
2. Scherer, P.E. 2006. Adipose tissue: from lipid storage compartment to endocrine organ. Diabetes. 55:1537-1545.
3. Arita, Y., et al. 1999. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem. Biophys. Res. Commun. 257:79-83.
4. Hotta, K., et al. 2000. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler. Thromb. Vasc. Biol. 20:1595-1599.
5. Iwashima, Y., et al. 2004. Hypoadiponectinemia is an independent risk factor for hypertension. Hypertension. 43:1318-1323.
6. Ouchi, N., et al. 2000. Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway. Circulation. 102:1296-1301.
7. Kubota, N., et al. 2002. Disruption of adiponectin causes insulin resistance and neointimal formation. J. Biol. Chem. 277:25863- 25866.
8. Matsuda, M., et al. 2002. Role of adiponectin in preventing vascular stenosis. The missing link of adipo-vascular axis. J. Biol. Chem. 277:37487-37491.
9. Lefer, A.M., and Scalia, R. 2001. Nitric oxide in inflammation. In Physiology of inflammation. K. Ley, editor. Oxford University Press. New York, New York, USA. 447-472.
10. Kubes, P., Suzuki, M., and Granger, D.N. 1991. Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc. Natl. Acad. Sci. U. S. A. 88:4651-4655.
11. De Caterina, R., et al. 1995. Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J. Clin. Invest. 96:60-68.
12. Davenpeck, K.L., Gauthier, T.W., and Lefer, A.M. 1994. Inhibition of endothelial-derived nitric oxide promotes P-selectin expression and actions in the rat microcirculation Gastroenterology. 107:1050-1058.
13. Ouchi, N., et al. 2003. Association of hypoadiponectinemia with impaired vasoreactivity. Hypertension. 42:231-234.
14. Tan, K.C., et al. 2004. Hypoadiponectinemia is associated with impaired endothelium-dependent vasodilation. J. Clin. Endocrinol. Metab. 89:765-769.
15. Chen, H., Montagnani, M., Funahashi, T., Shimomura, I., and Quon, M.J. 2003. Adiponectin stimulates production of nitric oxide in vascular endothelial cells. J. Biol. Chem. 278:45021-45026.
16. Motoshima, H., Wu, X., Mahadev, K., and Goldstein, B.J. 2004. Adiponectin suppresses proliferation and superoxide generation and enhances eNOS activity in endothelial cells treated with oxidized LDL. Biochem. Biophys. Res. Commun. 315:264-271.
17. Joussen, A.M., et al. 2004. A central role for inflammation in the pathogenesis of diabetic retinopathy. FASEB J. 18:1450-1452.
18. Ouchi, N., et al. 1999. Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation. 100:2473-2476.
19. Ma, K., et al. 2002. Increased beta-oxidation but no insulin resistance or glucose intolerance in mice lacking adiponectin. J. Biol. Chem. 277:34658-34661.
20. Kunkel, E.J., and Ley, K. 1996. Distinct phenotype of E-selectin-deficient mice. E-selectin is required for slow leukocyte rolling in vivo. Circ. Res. 79:1196-1204.
21. Ouedraogo, R., et al. 2006. Adiponectin suppression of high-glucose-induced reactive oxygen species in vascular endothelial cells: evidence for involvement of a cAMP signaling pathway. Diabetes. 55:1840-1846.
22. Goldstein, B.J., and Scalia, R. 2007. Adipokines and vascular disease in diabetes. Curr. Diab. Rep. 7:25-33.
23. Valerio, A., et al. 2006. TNF-α downregulates eNOS expression and mitochondrial biogenesis in fat and muscle of obese rodents. J. Clin. Invest. 116:2791-2798. doi:10.1172/JCI28570.
24. Picchi, A., et al. 2006. Tumor necrosis factor-alpha induces endothelial dysfunction in the prediabetic metabolic syndrome. Circ. Res. 99:69-77.
25. Neumann, P., Gertzberg, N., and Johnson, A. 2004. TNF-alpha induces a decrease in eNOS promoter activity. Am. J. Physiol. Lung Cell. Mol. Physiol. 286:L452-L459.
26. Pruefer, D., Scalia, R., and Lefer, A.M. 1999. Simvastatin inhibits leukocyte-endothelial cell interactions and protects against inflammatory processes in normocholesterolemic rats. Arterioscler. Thromb. Vasc. Biol. 19:2894-2900.
27. Lefer, D.J., et al. 1999. Leukocyte-endothelial cell interactions in nitric oxide synthase-deficient mice. Am. J. Physiol. 276:H1943-H1950.
28. Ley, K., Allietta, M., Bullard, D.C., and Morgan, S. 1998. Importance of E-selectin for firm leukocyte adhesion in vivo. Circ. Res. 83:287-294.
29. Milstone, D.S., et al. 1998. Mice lacking E-selectin show normal numbers of rolling leukocytes but reduced leukocyte stable arrest on cytokine-activated microvascular endothelium. Microcirculation. 5:153-171.
30. Krieglstein, C.F., and Granger, D.N. 2001. Adhesion molecules and their role in vascular disease. Am. J. Hypertens. 14:44S-54S.
31. Carlos, T.M., and Harlan, J.M. 1994. Leukocyte-endothelial adhesion molecules. Blood. 84:2068-2101.
32. Weiss, S.J. 1989. Tissue destruction by neutrophils. N. Engl. J. Med. 320:365-376.
33. Festa, A., et al. 2001. The relation of body fat mass and distribution to markers of chronic inflammation. Int. J. Obes. Relat. Metab. Disord. 25:1407-1415.
34. Fruhbeck, G., Gomez-Ambrosi, J., Muruzabal, F.J., and Burrell, M.A. 2001. The adipocyte: a model for integration of endocrine and metabolic signaling in energy metabolism regulation. Am. J. Physiol. Endocrinol. Metab. 280:E827-E847.
35. Trayhurn, P., and Wood, I.S. 2004. Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br. J. Nutr. 92:347-355.
36. Arita, Y., et al. 1999. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem. Biophys. Res. Commun. 257:79-83.
37. Shimabukuro, M., et al. 2003. Hypoadiponectinemia is closely linked to endothelial dysfunction in man. J. Clin. Endocrinol. Metab. 88:3236-3240.
38. Fernandez-Real, J.M., et al. 2004. Adiponectin is associated with vascular function independent of insulin sensitivity. Diabetes Care. 27:739-745.
39. Kubota, N., et al. 2002. Disruption of adiponectin causes insulin resistance and neointimal formation. J. Biol. Chem. 277:25863- 25866.
40. Yamauchi, T., et al. 2003. Globular adiponectin protected ob/ob mice from diabetes and ApoE-deficient mice from atherosclerosis. J. Biol. Chem. 278:2461-2468.
41. Okamoto, Y., et al. 2002. Adiponectin reduces atherosclerosis in apolipoprotein E-deficient mice. Circulation. 106:2767-2770.
42. Okamoto, Y., et al. 2000. An adipocyte-derived plasma protein, adiponectin, adheres to injured vascular walls. Horm. Metab. Res. 32:47-50.
43. Nakanishi, S., et al. 2005. A protective effect of adiponectin against oxidative stress in Japanese Americans: the association between adiponectin or leptin and urinary isoprostane. Metabolism. 54:194-199.
44. Nakashima, Y., Raines, E.W., Plump, A.S., Breslow, J.L., and Ross, R. 1998. Upregulation of VCAM-1 and ICAM-1 at atherosclerosis-prone sites on the endothelium in the ApoE-deficient mouse. Arterioscler. Thromb. Vasc. Biol. 18:842-851.
45. O'Brien, K.D., et al. 1993. Vascular cell adhesion molecule-1 is expressed in human coronary atherosclerotic plaques. Implications for the mode of progression of advanced coronary atherosclerosis. J. Clin. Invest. 92:945-951.
46. Luscinskas, F.W., Ding, H., and Lichtman, A.H. 1995. P-selectin and vascular cell adhesion molecule 1 mediate rolling and arrest, respectively, of CD4+ T lymphocytes on tumor necrosis factor alpha-activated vascular endothelium under flow. J. Exp. Med. 181:1179-1186.
47. Matsushita, K., et al. 2003. Nitric oxide regulates exocytosis by S-nitrosylation of N-ethylmaleimide-sensitive factor. Cell. 115:139-150.
48. Collins, T., et al. 1995. Transcriptional regulation of endothelial cell adhesion molecules: NF-kappa B and cytokine-inducible enhancers. FASEB J. 9:899-909.
49. Ghosh, S., May, M.J., and Kopp, E.B. 1998. NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 16:225-260.
50. Fruebis, J., et al. 2001. Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc. Natl. Acad. Sci. U. S. A. 98:2005-2010.
51. Madge, L.A., and Pober, J.S. 2001. TNF signaling in vascular endothelial cells. Exp. Mol. Pathol. 70:317-325.
52. Fernandez-Real, J.M., and Ricart, W. 2003. Insulin resistance and chronic cardiovascular inflammatory syndrome. Endocr. Rev. 24:278-301.
53. Kuroki, T., Isshiki, K., and King, G.L. 2003. Oxidative stress: the lead or supporting actor in the pathogenesis of diabetic complications. J. Am. Soc. Nephrol. 14:S216-S220.
54. Singleton, J.R., Smith, A.G., Russell, J.W., and Feldman, E.L. 2003. Microvascular complications of impaired glucose tolerance. Diabetes. 52:2867-2873.
55. Zou, M.H., Shi, C., and Cohen, R.A. 2002. Oxidation of the zinc-thiolate complex and uncoupling of endothelial nitric oxide synthase by peroxynitrite. J. Clin. Invest. 109:817-826. doi:10.1172/JCI200214442.
56. Aljada, A., Ghanim, H., Assian, E., and Dandona, P. 2002. Tumor necrosis factor-alpha inhibits insulin-induced increase in endothelial nitric oxide synthase and reduces insulin receptor content and phosphorylation in human aortic endothelial cells. Metabolism. 51:487-491.
57. Xi, W., Satoh, H., Kase, H., Suzuki, K., and Hattori, Y. 2005. Stimulated HSP90 binding to eNOS and activation of the PI3-Akt pathway contribute to globular adiponectin-induced NO production: vasorelaxation in response to globular adiponectin. Biochem. Biophys. Res. Commun. 332:200-205.
58. Ramos, C.L., et al. 1997. Differential effect of E-selectin antibodies on neutrophil rolling and recruitment to inflammatory sites. Blood. 89:3009-3018.
59. Wang, Y., et al. 2006. Post-translational modifications of the four conserved lysine residues within the collagenous domain of adiponectin are required for the formation of its high molecular weight oligomeric complex. J. Biol. Chem. 281:16391-16400.
60. Smith, M.L., Long, D.S., Damiano, E.R., and Ley, K. 2003. Near-wall micro-PIV reveals a hydrodynamically relevant endothelial surface layer in venules in vivo. Biophys. J. 85:637-645.
61. Scalia, R., Armstead, V.E., Minchenko, A.G., and Lefer, A.M. 1999. Essential role of P-selectin in the initiation of the inflammatory response induced by hemorrhage and reinfusion. J. Exp. Med. 189:931-938.
62. Lefer, D.J., et al. 1997. Peroxynitrite inhibits leukocyte-endothelial cell interactions and protects against ischemia-reperfusion injury in rats. J. Clin. Invest. 99:684-691.
63. Yuan, Y., and Fleming, B.P. 1990. A method for isolation and fluorescent labeling of rat neutrophils for intravital microvascular studies. Microvasc. Res. 40:218-229.
64. Booth, G., Stalker, T.J., Lefer, A.M., and Scalia, R. 2001. Elevated ambient glucose induces acute inflammatory events in the microvasculature: effects of insulin. Am. J. Physiol. Endocrinol. Metab. 280:E848-E856.
65. Guo, J.P., Murohara, T., Buerke, M., Scalia, R., and Lefer, A.M. 1996. Direct measurement of nitric oxide release from vascular endothelial cells. J. Appl. Physiol. 81:774-779.
66. Scalia, R., Gefen, J., Petasis, N.A., Serhan, C.N., and Lefer, A.M. 1997. Lipoxin A4 stable analogs inhibit leukocyte rolling and adherence in the rat mesenteric microvasculature: role of P-selectin. Proc. Natl. Acad. Sci. U. S. A. 94:9967-9972.
67. Weyrich, A.S., Buerke, M., Albertine, K.H., and Lefer, A.M. 1995. Time course of coronary vascular endothelial adhesion molecule expression during reperfusion of the ischemic feline myocardium. J. Leukoc. Biol. 57:45-55.